INTRODUCTION
Spinal cord stimulation (SCS) for patients with failed back surgery syndrome (FBSS) is a relatively safe technique that has been demonstrated to be effective in providing long-term pain relief and improving quality of life. 1 FBSS is a loosely defined term that encompasses multifactorial persistent back and/or leg pain following spine surgery. 2 While the risk for life-threatening complications related to SCS is low, several have nonetheless been documented. Lead migration is the most common complication, but others include surgical site infection, electrode fracture, implantable pulse generator failure, cerebral spinal fluid leakage, pain at surgical or implant site, epidural abscess, and epidural hematoma. 3 An epidural abscess is generally associated with poor outcomes and high morbidity, 4 with an incidence of 0.2 to 2 cases per 10,000 hospital admissions.
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Staphylococcus aureus is the most common causative organism for a spinal epidural abscess, with associated independent risk factors including diabetes mellitus, spinal trauma, prior spinal surgery, a history of multiple lab draws, an immunocompromised state, intravenous drug use, and alcoholism. 5, 6 Due to medical advances such as magnetic resonance imaging (MRI), broad-spectrum antibiotics, and advanced surgical techniques, mortality rates dropped from 34% in the mid-1950s to 15% in the mid-1990s. 5 Approximately half of epidural abscess cases occur via hematogenous spread of bacteria, and approximately one-third occur via contiguous spread. 7 In a review of 915 cases of epidural abscesses, only 5.5% were attributed to epidural anesthesia or analgesia. 5 An Institute of Medicine report suggests that 100 million Americans suffer from chronic pain, and approximately one-fifth of these are afflicted with moderate to severe pain daily. 8 Many of these individuals have spine-related pain complaints. There is limited evidence for the efficacy of long-term opioid use for the management of noncancer chronic pain and, in light of the rising opioid epidemic, it is essential to explore nonopioid alternatives for the management of chronic spinerelated pain. Therefore, it is reasonable to expect a rise in the utilization of minimally invasive spinal procedures such as percutaneous SCS for pain refractory to conventional conservative management in select patients, especially as recent evidence suggests an opioid-sparing effect of SCS.
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CASE
The patient was a 54-year-old immunocompetent female with a long history of back pain associated with lumbar degenerative disc disease and episodic lumbar radiculopathy. Conservative management included physical therapy, cognitive behavioral therapy, chronic oral narcotics, adjuvant medications, and various minimally invasive interventional procedures. Prior history also included lumbar discectomy. After limited response to conservative therapy, she decided to pursue an SCS trial with traditional tonic stimulation. Institutional review board approval was waived for this case report. Two grams of intravenous cephazolin was administered prior to incision. The skin was then prepared with chlorhexidine, and two Medtronic â Octad trial leads were placed under sterile conditions using fluoroscopy guidance. The epidural space was accessed at T12 to L1. Tonic stimulation was mapped without difficulty after confirmation of dual lead placement under fluoroscopy in the dorsal epidural space at T9 to 10. The insertion site was covered with sterile dressing and adhesive tape. The patient was discharged home shortly after the procedure with no complaints or signs of complications. On day 3, the patient reported a greater than 50% reduction in baseline pain, but had focal sharp incisional pain at the trial lead insertion site. She was evaluated in clinic and was found to be afebrile, hemodynamically stable, and without neurological deficits. The insertion sites were clean, dry, and showed no signs of drainage, erythema, or induration. On day 4, she became subjectively febrile with increasing back pain. She presented to an outside hospital where the leads were removed. The insertion sites at the skin were swabbed, cultured, and would eventually be suggestive for methicillin-sensitive S. aureus. The patient was recorded as being afebrile with leukocytosis before being discharged home on oral cephalexin. On day 5, she developed a headache and returned to the outside hospital where she had nuchal rigidity, photophobia, and was febrile. Broad-spectrum intravenous antibiotics consisting of vancomycin and ceftriaxone were started, and the patient was then transferred to our institution.
At our facility, an MRI of the lumbar spine demonstrated an epidural fluid collection from T11 to L2 (Figure 1 ). Antibiotics were broadened to intravenous vancomycin, cefepime, and ampicillin. Blood cultures and Gram stain were negative. Findings from a complete blood count (CBC) test were consistent with leukocytosis with a white blood cell count of 15,300 cells/lL. A lumbar puncture was performed that demonstrated 200 red blood cells/lL, 2,350 white blood cells/lL, increased protein at 254 mg/dL, glucose of 53 mg/dL, and many neutrophils. Results of cerebral spinal fluid Gram staining were negative and no organism was grown on culture. On clinical examination, the patient demonstrated increased focal back pain without neurologic compromise. Weakness, numbness, or myelopathy was not appreciated on examination. Surgical intervention was deferred. The patient was ultimately discharged home with 6 weeks of intravenous cefepime. At a followup appointment, a repeat MRI of the lumbar spine demonstrated a resolving epidural abscess (Figure 2 ).
DISCUSSION
The case presented demonstrates that an acute, severe, and emergent complication can arise from an SCS trial despite strict aseptic technique and prophylactic preprocedural antibiotics. Equally concerning is the rapid onset of the epidural abscess. An epidural abscess can be difficult to diagnose, with the most common symptom being back pain. 10 Other clinical findings may include, but are not limited to, new or worsening neurological symptoms such as motor or sensory weakness and bowel or bladder incontinence. Due to advanced imaging such as MRI, spinal epidural abscesses are being detected earlier and an increasing number of patients are being managed medically. 11 In addition to the aforementioned risk factors for epidural abscess, external factors that could affect the probability of an infection include proper wound care, patient education, and compliance. An epidural abscess is a rare occurrence, and a search of the literature yielded very few cases during an SCS trial.
12, 13 In our case, the patient had chronic back pain due to postlaminectomy syndrome with radiculopathy, no history of intravenous drug use, alcoholism, chronic steroid use, recent infections, or epidural steroid injections. There were also no obvious clinical signs of infection on her initial follow-up visit. Despite sterile conditions, pre-procedure antibiotics, and proper dressing, this patient developed an abscess within 72 to 96 hours of the procedure. She also had no prior medical history of an immunocompromised state or other significant risk factors. While the patient did have a prior history of spinal surgery, it is unclear how significant this factor is considering the patient's lumbar laminectomy was years ago. It may be challenging to differentiate focal back pain from acute or chronic pain, expected post-procedural pain, or a new entity such as an abscess.
CONCLUSION
Physicians pursuing SCS for their patients must be aware of the nonspecific findings of an abscess and weigh the potential benefit of a shortened trial duration compared with the risk for a deep infection. Interpreting back pain following an SCS trial can be particularly challenging as the pain could be a result of a variety of contributing factors. Prompt removal of the leads, cultures of the site, appropriate imaging, and the institution of broad-spectrum antibiotics are imperative for a good outcome in the case of an infection. Surgical evaluation may be necessary if neurological changes develop or fluid collection is seen on imaging. A high level of vigilance is required, as even a brief SCS trial does not entirely preclude the risk for developing a potentially catastrophic epidural abscess. Figure 2 . Sagittal T2 view of the lumbar spine 6 weeks later with resolution of the epidural abscess. Arrow points towards the epidural abscess.
